Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001879 · ClinicalTrials.gov registry record

Collections of Blood and Stool Samples in Patients With Acute Hepatitis

A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
200
Enrollment target

NCT00001879 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001879 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
200 participants
Enrollment target

Study Summary

Hepatitis is an inflammation of the liver. Hepatitis can be caused by an infection with a virus, but poisonous (toxic) substances can also cause it. Researchers have identified several of the viruses responsible for hepatitis, however some patients with hepatitis show no evidence of being infected with known hepatitis viruses. Researchers call conditions like this, seronegative hepatitis. It means that a patient has hepatitis but he/she does not have evidence in their blood of a viral infection. Seronegative hepatitis is often complicated by autoimmune disorders and associated severe disorders especially, fulminant hepatitis of childhood and post-hepatitis aplastic anemia. Researchers have attempted to identify the cause of these conditions but have been unsuccessful. Therefore, this study was developed to collect blood and stool samples from patients with seronegative hepatitis in order to help identify the virus responsible.

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 1999-03
Est. Completion 2001-03

What the Registry Record Tells You About NCT00001879

The ClinicalTrials.gov registry entry for NCT00001879 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001879 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001879 about?

NCT00001879 is a clinical study titled "Collections of Blood and Stool Samples in Patients With Acute Hepatitis". Hepatitis is an inflammation of the liver. Hepatitis can be caused by an infection with a virus, but poisonous (toxic) substances can also cause it. Researchers have identified several of the viruses responsible for hepatitis, however some patients with hepatitis show no evidence of being infected w...

What is the current status of trial NCT00001879?

This trial is currently completed. The enrollment target is 200 participants. The study started on 1999-03. Estimated completion is 2001-03.

Who is sponsoring clinical trial NCT00001879?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.